Cargando…
Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases
Background: The melanocortin α-melanocyte stimulating hormone (α-MSH), an endogenous peptide with high affinity for the melanocortin 1 receptor (MC1r), has demonstrated prevention and reversal of intestinal and ocular inflammation in animal models. Preclinical studies were performed to determine whe...
Autores principales: | Spana, Carl, Taylor, Andrew W., Yee, David G., Makhlina, Marie, Yang, Wei, Dodd, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339910/ https://www.ncbi.nlm.nih.gov/pubmed/30692924 http://dx.doi.org/10.3389/fphar.2018.01535 |
Ejemplares similares
-
Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
por: Dodd, John, et al.
Publicado: (2021) -
A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans
por: Dodd, John, et al.
Publicado: (2023) -
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease
por: Evans, David, et al.
Publicado: (2023) -
The Importance of Melanocortin Receptors and Their Agonists in Pulmonary Disease
por: Moscowitz, Anna Elizabeth, et al.
Publicado: (2019) -
Effects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies
por: Lindskog Jonsson, Annika, et al.
Publicado: (2014)